Analytical and Clinical Validation of a Prostate Cancer-Enhanced messenger RNA Detection Assay in Whole Blood as a Prognostic Biomarker for Survival

BACKGROUND: Biomarkers based on detecting prostate cancer-specific transcripts are associated with inferior outcomes, but their validation in a clinical context is lacking. OBJECTIVE: To determine whether detecting prostate cancer enhanced transcripts in whole blood using an analytically valid assay...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Danila, Daniel C., Anand, Aseem, Schultz, Nikolaus, Heller, Glenn, Wan, Mingliang, Sung, Clifford C., Dai, Charles, Khanin, Raya, Fleisher, Martin, Lilja, Hans, Scher, Howard I.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4113474/
https://ncbi.nlm.nih.gov/pubmed/23954088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2013.07.006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars